How to optimise TAVI outcomes in the Asian-Pacific population?

Sponsored by Abbott

Anchorperson: K. Hayashida

Spokesperson: D. Tchetche

Summary

What are the key considerations for TAVI in Asian-Pacific patients? This EuroPCR 2025 session focuses on optimising outcomes in anatomically and clinically specific contexts, such as patients with small annuli. Learn how the latest intra-annular self-expanding devices can help reduce post-procedural pacemaker implantation (PPI) rates, and how thoughtful valve selection at index procedure can support effective lifetime management. Get concrete guidance from focused presentations designed to support tailored decision-making and improve procedural success in this diverse patient population.

Learning Objectives

To understand how to optimise clinical outcomes for TAVI patients with small annuli
To learn how to mitigate the risk of conduction disturbances after TAVI
To discuss how to optimise lifetime management for TAVI patients

Speaker

M. Yamamoto

How to optimise TAVI outcomes in patients with small annuli?

Download presentation

Speaker

Y. Ohno

How to achieve low PPI rates with the latest intra-annular self-expanding TAVI device?